p.129 抽出テキスト

与を推奨する。

【引用文献】1) Nosek K, Leppert W, Nosek H, et al. A comparison of oral controlled‒release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. Drug Des Devel Ther 2017;11:2409‒19 2) Lee KH, Kang JH, Oh HS, et al. Intravenous oxycodone versus intravenous morphine in cancer pain:a randomized, open‒label, parallel‒group, active‒control study. Pain Res Manag 2017; 2017:9741729 3) Corli O, Floriani I, Roberto A, et al.;CERP STUDY OF PAIN GROUP. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phaseIVʻreal lifeʼtrial on the variability of response to opioids. Ann Oncol 2016;27:1107‒15 4) Imanaka K, Tominaga Y, Etropolski M, et al. Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor‒ related pain. Curr Med Res Opin 2013;29:1399‒409 5) Lux EA, Janecki M, Maritz MA. Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain:a randomized, double‒blind, multicenter, cross‒over, non‒inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet. Curr Med Res Opin 2014;30: 2365‒75 6) Mercadante S, Tirelli W, David F, et al. Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain 2010;26:794‒7 7) Riley J, Branford R, Droney J, et al. Morphine or oxycodone for cancer‒related pain? A randomized, open‒label, controlled trial. J Pain Symptom Manage 2015;49:161‒72 8) Su J, Zhu Y, Wu W, et al. Observation of curative effects and adverse effects of oxycodone hydrochloride controlled‒ release tablets and fentanyl transdermal patches on the treatment of moderate or severe cancer pain. Anti‒Tumor Pharmacy 2015;5(6):444‒8 9) Yu S, Shen W, Yu L, et al. Safety and efficacy of once‒daily hydromorphone extended‒release versus twice‒daily oxycodone hydrochloride controlled‒release in chinese patients with cancer pain:a phase 3, randomized, double‒blind, multicenter study. J Pain 2014;15:835‒44 10) Zecca E, Brunelli C, Bracchi P, et al. Comparison of the tolerability profile of controlled‒release oral morphine and oxycodone for cancer pain treatment. An open‒label randomized controlled trial. J Pain Symptom Manage 2016;52:783‒94. 11) Zhang W‒Z, Yu W‒J, Zhao X‒L, et al. Pharmacoeconomics evaluation of morphone, MS Contin and oxycodone in the treatment of cancer pain. Asian Pac J Cancer Prev 2014;15:8797‒800 12) Beaver WT, Wallenstein SL, Rogers A, et al. Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone. J Pharmacol Exp Ther 1978;207:92‒100 13) Beaver WT, Wallenstein SL, Rogers A, et al. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. J Pharmacol Exp Ther 1978;207:101‒8 14) Bruera E, Belzile M, Pituskin E, et al. Randomized, double‒blind, cross‒over trial comparing safety and efficacy of oral controlled‒release oxycodone with controlled‒release morphine in patients with cancer pain. J Clin Oncol 1998;16:3222‒9 15) Gabrail NY, Dvergsten C, Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain:a randomized controlled study. Curr Med Res Opin 2004;20:911‒8 16) Hagen NA, Babul N. Comparative clinical efficacy and safety of a novel controlled‒release oxycodone formulation and controlled‒release hydromorphone in the treatment of cancer pain. Cancer 1997;79:1428‒37 17) Heiskanen T, Kalso E. Controlled‒release oxycodone and morphine in cancer related pain. Pain 1997;73:37‒45 18) Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 1990;47:639‒46 19) Kaplan R, Parris WC, Citron ML, et al. Comparison of controlled‒release and immediate‒ release oxycodone tablets in patients with cancer pain. J Clin Oncol 1998;16:3230‒7 20) Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained‒release morphine with sus-

tained‒release oxycodone in advanced cancer patients. Br J Cancer 2003;89:2027‒30